131 related articles for article (PubMed ID: 8442245)
1. Evidence that a "four-cell cluster" may prime cytotoxic T-cells during graft rejection.
Lee R; Glimcher LH; Auchincloss H
Transplant Proc; 1993 Feb; 25(1 Pt 2):847-9. PubMed ID: 8442245
[No Abstract] [Full Text] [Related]
2. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
Rosenberg AS
Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
[No Abstract] [Full Text] [Related]
3. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
Campos HH; Bach JF; Chatenoud L
Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
[No Abstract] [Full Text] [Related]
4. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
Maeda H; Ogoshi S; Fujimoto S
Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
[No Abstract] [Full Text] [Related]
5. Effect of FK 506 on CD4+ and CD8+ T-cell function in vivo.
Fukuzawa M; Okada A; Shearer GM
Transplant Proc; 1991 Dec; 23(6):2945-7. PubMed ID: 1721321
[No Abstract] [Full Text] [Related]
6. Alloreactive T cells that do not require TCR and CD8 coengagement are present in naive mice and contribute to graft rejection.
Smith PA; Potter TA
J Immunol; 1998 Jun; 160(11):5382-9. PubMed ID: 9605138
[TBL] [Abstract][Full Text] [Related]
7. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
8. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
9. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
10. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
11. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
12. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent.
Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
Transplant Proc; 1990 Jun; 22(3):1059-60. PubMed ID: 1971971
[No Abstract] [Full Text] [Related]
13. Mechanism of rejection of MHC class I-disparate murine skin grafts--histological and immunohistochemical studies of the rejection phenomenon.
Kobayashi E; Kawai K; Ito M; Matsumoto Y; Fujiwara M
Transplant Proc; 1990 Oct; 22(5):2352-7. PubMed ID: 2219400
[No Abstract] [Full Text] [Related]
14. Xenograft rejection of class I-expressing transgenic skin is CD4-dependent and CD8-independent.
Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
Transplant Proc; 1990 Oct; 22(5):2335-6. PubMed ID: 2120817
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of rejection of MHC class II-disparate murine skin grafts. I. Immunohistochemical analysis of T-cell subsets infiltrating the site of the graft.
Kobayashi E; Fujiwara M
Transplant Proc; 1992 Feb; 24(1):419-22. PubMed ID: 1531715
[No Abstract] [Full Text] [Related]
16. Inhibitory effect of the complement receptor-specific monoclonal antibody on the induced antibody response and the role of CD4+ and CD8+ T-cells in the rat to mouse xenotransplantation.
Matsumiya G; Shirakura R; Miyagawa S; Nakata S; Nakano S; Kinoshita T; Matsuda H
Transplant Proc; 1993 Feb; 25(1 Pt 1):402-4. PubMed ID: 8438354
[No Abstract] [Full Text] [Related]
17. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.
Benichou G; Valujskikh A; Heeger PS
J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406
[TBL] [Abstract][Full Text] [Related]
18. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
Yamada J; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]